These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 21360497)

  • 1. Cytosolic phospholipase A2α gene silencing in the myeloid lineage alters development of Th1 responses and reduces disease severity in collagen-induced arthritis.
    Courties G; Baron M; Presumey J; Escriou V; van Lent P; Scherman D; Cantagrel A; van den Berg WB; Jorgensen C; Apparailly F; Davignon JL
    Arthritis Rheum; 2011 Mar; 63(3):681-90. PubMed ID: 21360497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficient suppression of murine arthritis by combined anticytokine small interfering RNA lipoplexes.
    Khoury M; Escriou V; Courties G; Galy A; Yao R; Largeau C; Scherman D; Jorgensen C; Apparailly F
    Arthritis Rheum; 2008 Aug; 58(8):2356-67. PubMed ID: 18668557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced Th1 and Th17 responses and arthritis severity in mice with a deficiency of myeloid cell-specific interleukin-1 receptor antagonist.
    Lamacchia C; Palmer G; Seemayer CA; Talabot-Ayer D; Gabay C
    Arthritis Rheum; 2010 Feb; 62(2):452-62. PubMed ID: 20112392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient new cationic liposome formulation for systemic delivery of small interfering RNA silencing tumor necrosis factor alpha in experimental arthritis.
    Khoury M; Louis-Plence P; Escriou V; Noel D; Largeau C; Cantos C; Scherman D; Jorgensen C; Apparailly F
    Arthritis Rheum; 2006 Jun; 54(6):1867-77. PubMed ID: 16729293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune modulation of collagen-induced arthritis by intranasal cytokine gene delivery: a model for the therapy of rheumatoid arthritis.
    Woods AM; Thompson SJ; Wooley PH; Panayi G; Klavinskis LS
    Arthritis Rheum; 2005 Dec; 52(12):3761-71. PubMed ID: 16329091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional characterization of myeloid-derived suppressor cell subpopulations during the development of experimental arthritis.
    Wang W; Jiao Z; Duan T; Liu M; Zhu B; Zhang Y; Xu Q; Wang R; Xiong Y; Xu H; Lu L
    Eur J Immunol; 2015 Feb; 45(2):464-73. PubMed ID: 25352399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nicotinamide phosphoribosyltransferase/visfatin expression by inflammatory monocytes mediates arthritis pathogenesis.
    Présumey J; Courties G; Louis-Plence P; Escriou V; Scherman D; Pers YM; Yssel H; Pène J; Kyburz D; Gay S; Jorgensen C; Apparailly F
    Ann Rheum Dis; 2013 Oct; 72(10):1717-24. PubMed ID: 23313810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adeno-associated virus type 5-mediated intraarticular administration of tumor necrosis factor small interfering RNA improves collagen-induced arthritis.
    Khoury M; Courties G; Fabre S; Bouffi C; Seemayer CA; Vervoordeldonk MJ; Tak PP; Jorgensen C; Apparailly F
    Arthritis Rheum; 2010 Mar; 62(3):765-70. PubMed ID: 20187132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of experimental arthritis by inducing immune tolerance with human adipose-derived mesenchymal stem cells.
    González MA; Gonzalez-Rey E; Rico L; Büscher D; Delgado M
    Arthritis Rheum; 2009 Apr; 60(4):1006-19. PubMed ID: 19333946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of TNF-alpha expression, inhibition of Th1 activity, and amelioration of collagen-induced arthritis by rolipram.
    Ross SE; Williams RO; Mason LJ; Mauri C; Marinova-Mutafchieva L; Malfait AM; Maini RN; Feldmann M
    J Immunol; 1997 Dec; 159(12):6253-9. PubMed ID: 9550429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amphoteric liposomes enable systemic antigen-presenting cell-directed delivery of CD40 antisense and are therapeutically effective in experimental arthritis.
    Andreakos E; Rauchhaus U; Stavropoulos A; Endert G; Wendisch V; Benahmed AS; Giaglis S; Karras J; Lee S; Gaus H; Bennett CF; Williams RO; Sideras P; Panzner S
    Arthritis Rheum; 2009 Apr; 60(4):994-1005. PubMed ID: 19333921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion.
    Lubberts E; Koenders MI; Oppers-Walgreen B; van den Bersselaar L; Coenen-de Roo CJ; Joosten LA; van den Berg WB
    Arthritis Rheum; 2004 Feb; 50(2):650-9. PubMed ID: 14872510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumour necrosis factor receptor gene therapy affects cellular immune responses in collagen induced arthritis in mice.
    Mukherjee P; Yang SY; Wu B; Song Z; Myers LK; Robbins PD; Wooley PH
    Ann Rheum Dis; 2005 Nov; 64(11):1550-6. PubMed ID: 15860512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conversion in vivo from an early dominant Th0/Th1 response to a Th2 phenotype during the development of collagen-induced arthritis.
    Doncarli A; Stasiuk LM; Fournier C; Abehsira-Amar O
    Eur J Immunol; 1997 Jun; 27(6):1451-8. PubMed ID: 9209498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GATA-3 protects against severe joint inflammation and bone erosion and reduces differentiation of Th17 cells during experimental arthritis.
    van Hamburg JP; Mus AM; de Bruijn MJ; de Vogel L; Boon L; Cornelissen F; Asmawidjaja P; Hendriks RW; Lubberts E
    Arthritis Rheum; 2009 Mar; 60(3):750-9. PubMed ID: 19248112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amelioration of collagen-induced arthritis and suppression of interferon-gamma, interleukin-12, and tumor necrosis factor alpha production by interferon-beta gene therapy.
    Triantaphyllopoulos KA; Williams RO; Tailor H; Chernajovsky Y
    Arthritis Rheum; 1999 Jan; 42(1):90-9. PubMed ID: 9920019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down-regulation of Th1-mediated pathology in experimental arthritis by stimulation of the Th2 arm of the immune response.
    Mauri C; Feldmann M; Williams RO
    Arthritis Rheum; 2003 Mar; 48(3):839-45. PubMed ID: 12632440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of treatment with small interfering RNA on joint inflammation in mice with collagen-induced arthritis.
    Schiffelers RM; Xu J; Storm G; Woodle MC; Scaria PV
    Arthritis Rheum; 2005 Apr; 52(4):1314-8. PubMed ID: 15818667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Splenic suppressor of cytokine signaling 3 transgene expression affects T cell responses and prevents development of collagen-induced arthritis.
    Veenbergen S; Bennink MB; de Hooge AS; Arntz OJ; Smeets RL; van den Berg WB; van de Loo FA
    Arthritis Rheum; 2008 Dec; 58(12):3742-52. PubMed ID: 19035473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial ICAM-1 protein induction is regulated by cytosolic phospholipase A2α via both NF-κB and CREB transcription factors.
    Hadad N; Tuval L; Elgazar-Carmom V; Levy R; Levy R
    J Immunol; 2011 Feb; 186(3):1816-27. PubMed ID: 21199900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.